Comparative efficacy and safety of Sofosbuvir/Velpatasvir and Danoprevir for the treatment of chronic hepatitis C: the real-world data in China.

Yunjing ZhouMinfeng LiangYiting LiXing ChenJie YangHonglian BaiYingzi LongXiaohong ZhangChaoshuang Lin

Published in: BMC gastroenterology (2024)

In this retrospective real-world study, the efficacy of DNV combined therapy is similar to Sofosbuvir/Velpatasvir ± Ribavirin for chronic HCV infection, and the safety is comparable. DNV based therapy is a promising regimen for chronic hepatitis C.

Keyphrases

hepatitis c virus
human immunodeficiency virus
liver fibrosis
hepatitis c virus infection
cross sectional
electronic health record
stem cells
big data
machine learning
replacement therapy
mesenchymal stem cells
data analysis